AZD8853
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD8853, covering 2024-10-01 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours [Phase 1, Phase 2]